No KRAS mutations found in gastrointestinal stromal tumors (GISTs): molecular genetic study of 514 cases (Q43506385)

24 November 2017

No KRAS mutations found in gastrointestinal stromal tumors (GISTs): molecular genetic study of 514 cases (English)

1 reference

24 November 2017

8

Markku Miettinen

1 reference

24 November 2017

1

Jerzy Lasota

1 reference

24 November 2017

Liqiang Xi

2

1 reference

24 November 2017

Tiffany Coates

3

1 reference

24 November 2017

RaShonda Dennis

4

1 reference

24 November 2017

Moses O Evbuomwan

5

1 reference

24 November 2017

Zeng-Feng Wang

6

1 reference

24 November 2017

Mark Raffeld

7

1 reference

24 November 2017

24 May 2013

1 reference

24 November 2017

1 reference

24 November 2017

26

1 reference

24 November 2017

11

1 reference

24 November 2017

1488-1491

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2013.89

24 November 2017

0 references

cites work

Histopathology of gastrointestinal stromal tumor

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.89

Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.89

KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.89

Differential properties of current tyrosine kinase inhibitors in gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.89

Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.89

Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.89

Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.89

Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.89

FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.89

Ras in cancer and developmental diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.89

V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.89

Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.89

Spectrum of KIT/PDGFRA/BRAF mutations and Phosphatidylinositol-3-Kinase pathway gene alterations in gastrointestinal stromal tumors (GIST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.89

BRAF mutant gastrointestinal stromal tumor: first report of regression with BRAF inhibitor dabrafenib (GSK2118436) and whole exomic sequencing for analysis of acquired resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.89

Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.89

Drug development: Raise standards for preclinical cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.89

H-ras and K-ras gene mutations in primary human soft tissue sarcoma: concomitant mutations of the ras genes

21 January 2018

1 reference

12 December 2020

Multiplicity of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC) patients treated with tyrosine kinase inhibitors

1 reference

12 December 2020

Acquired/intratumoral mutation of KRAS during metastatic progression of colorectal carcinogenesis

1 reference

12 December 2020

Detection of K-ras mutations in resected primary leiomyosarcoma.

1 reference

12 December 2020

Molecular characterization of an Italian series of sporadic GISTs.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.89

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/MODPATHOL.2013.89

1 reference

Dimensions Publication ID

24 November 2017

0 references

1 reference